Integral Derivatives’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $2.35M | Buy |
31,187
+22,443
| +257% | +$1.69M | 0.06% | 7 |
|
|
2017
Q4 | $626K | Sell |
8,744
-29,413
| -77% | -$2.11M | 0.01% | 104 |
|
|
2017
Q3 | $3.09M | Sell |
38,157
-15,147
| -28% | -$1.23M | 0.06% | 24 |
|
|
2017
Q2 | $3.77M | Sell |
53,304
-4,066
| -7% | -$288K | 0.08% | 16 |
|
|
2017
Q1 | $3.9M | Buy |
57,370
+19,673
| +52% | +$1.34M | 0.07% | 16 |
|
|
2016
Q4 | $2.7M | Buy |
37,697
+9,649
| +34% | +$691K | 0.05% | 29 |
|
|
2016
Q3 | $2.22M | Buy |
28,048
+14,892
| +113% | +$1.18M | 0.05% | 35 |
|
|
2016
Q2 | $1.1M | Sell |
13,156
-21,523
| -62% | -$1.79M | 0.03% | 52 |
|
|
2016
Q1 | $3.19M | Buy |
+34,679
| New | +$3.19M | 0.1% | 16 |
|
|
2015
Q4 | – | Sell |
-10,142
| Closed | -$996K | – | 350 |
|
|
2015
Q3 | $996K | Sell |
10,142
-75,490
| -88% | -$7.41M | 0.03% | 93 |
|
|
2015
Q2 | $10M | Buy |
+85,632
| New | +$10M | 0.27% | 4 |
|
|
2015
Q1 | – | Sell |
-27,866
| Closed | -$2.63M | – | 395 |
|
|
2014
Q4 | $2.63M | Sell |
27,866
-27,171
| -49% | -$2.56M | 0.05% | 60 |
|
|
2014
Q3 | $5.86M | Buy |
55,037
+15,351
| +39% | +$1.63M | 0.1% | 21 |
|
|
2014
Q2 | $3.29M | Buy |
39,686
+30,231
| +320% | +$2.51M | 0.06% | 29 |
|
|
2014
Q1 | $670K | Buy |
9,455
+5,409
| +134% | +$383K | 0.01% | 167 |
|
|
2013
Q4 | $304K | Buy |
+4,046
| New | +$304K | ﹤0.01% | 262 |
|